Canada Plans 'Pause The Clock' Mechanism For Drug & Device Reviews
Executive Summary
Canada is proposing a clock stop in the drug review process to allow more time for the clarification of specific issues and help it meet its review deadlines.
You may also be interested in...
Pharma Fees To Soar In Canada Under Government Proposals
The licence evaluation fee Health Canada charges for drugs containing new active substances could jump by 76% under proposals by the government department, which says its current fees for pharma and medtech are outdated and need to change.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.